Difference between revisions of "MEDICATION-LIGNOCAINE"
From NeuroRehab.wiki
(Imported from text file) |
(Imported from text file) |
||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.< | ===== [[Summary Article|'''SUMMARY''']] ===== | ||
1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects. | |||
<br/>2. Indications: VF/pulseless or VT refractory to defibrillation. | |||
<br/> | |||
<br/>SE | |||
<br/>3. Nausea & vomiting. | |||
<br/> | |||
<br/>4. CNS: slurred speech, drowsiness, seizures. | |||
<br/>5. CVS: bradycardia, heart block, asystole. | |||
<br/> | |||
<br/>DOSAGE | |||
<br/>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered. | |||
[[Category:Medication]] | [[Category:Medication]] | ||
[[Category:Advanced Life Support]] | |||
Latest revision as of 11:31, 1 January 2023
SUMMARY
1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.
2. Indications: VF/pulseless or VT refractory to defibrillation.
SE
3. Nausea & vomiting.
4. CNS: slurred speech, drowsiness, seizures.
5. CVS: bradycardia, heart block, asystole.
DOSAGE
6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.
